Physician profile
Herbert Mao
NPI 1063075067
$4,256.05
in general payments reported to CMS, 2019-2025
7 companies · $3,641 in 2025
The $3,641 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $615 · 2025: $3,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,739 · Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,739.34 |
| Food and Beverage | $1,516.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,161.58 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $1,694.60 | 2025 | Persona, Avenir, Hammr Curved G7 Impactor |
| Stryker Corporation | $264.73 | 2025 | Mako, Pangea, Gamma |
| Left Coast Surgical INC | $66.46 | 2025 | |
| Shoulder Innovations, INC. | $28.45 | 2025 | Inset System |
| Heron Therapeutics, INC. | $23.96 | 2025 | Zynrelef |
| Bioventus LLC | $16.27 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Mao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.